Dr Reddy S Laboratories Ltd
-
{
- All
- News
-
Aurobindo Pharma Shares Hit 9-Month Low On US Price Fixing Lawsuit
The lawsuit, filed in the US District Court for the District of Connecticut by 20 US states, also named Heritage Pharmaceuticals Inc, a company owned by Emcure Pharma Ltd, as a "ring leader" of the price manipulation.
-
Aurobindo Pharma Shares Hit 9-Month Low On US Price Fixing Lawsuit
The lawsuit, filed in the US District Court for the District of Connecticut by 20 US states, also named Heritage Pharmaceuticals Inc, a company owned by Emcure Pharma Ltd, as a "ring leader" of the price manipulation.
-
Dr Reddy's, TR-Pharm Announce Collaboration For 3 Biosimilars
Pharma major Dr Reddy's Laboratories Ltd has entered into a strategic collaboration agreement with Turkey-based TR-Pharm involving three biosimilar products.
-
US Regulator Gives Dr Reddy's Additional Time to Respond to Warning Letter
Dr Reddy's Laboratories Ltd (DRL) on Thursday said the US Food and Drug Administration (FDA) has extended the time for replying to the warning letter issued to the company by about two weeks to December 7.
-
US Court Imposes Temporary Sales Ban on Dr Reddy's Generic Heartburn Drug
Dr Reddy's Laboratories Ltd, India's second largest drug maker by sales, said on Tuesday it had been temporarily barred by a US court from selling its generic form of blockbuster heartburn drug Nexium in the United States.
-
AstraZeneca, Dr Reddy's Ink Diabetes Drug Distribution Pact
AstraZeneca Pharma India and Dr Reddy's Laboratories on Friday entered into a distribution agreement for two drugs - Riax and Riax-M - used for treatment of diabetes in India.
-
Dr Reddy's to Buy Select Brands From UCB for $128 Million
The deal will help Dr Reddy's strengthen its presence in dermatology, pediatrics and respiratory products, the company said in a statement to the Bombay Stock Exchange.
-
Aurobindo Pharma Shares Hit 9-Month Low On US Price Fixing Lawsuit
The lawsuit, filed in the US District Court for the District of Connecticut by 20 US states, also named Heritage Pharmaceuticals Inc, a company owned by Emcure Pharma Ltd, as a "ring leader" of the price manipulation.
-
Aurobindo Pharma Shares Hit 9-Month Low On US Price Fixing Lawsuit
The lawsuit, filed in the US District Court for the District of Connecticut by 20 US states, also named Heritage Pharmaceuticals Inc, a company owned by Emcure Pharma Ltd, as a "ring leader" of the price manipulation.
-
Dr Reddy's, TR-Pharm Announce Collaboration For 3 Biosimilars
Pharma major Dr Reddy's Laboratories Ltd has entered into a strategic collaboration agreement with Turkey-based TR-Pharm involving three biosimilar products.
-
US Regulator Gives Dr Reddy's Additional Time to Respond to Warning Letter
Dr Reddy's Laboratories Ltd (DRL) on Thursday said the US Food and Drug Administration (FDA) has extended the time for replying to the warning letter issued to the company by about two weeks to December 7.
-
US Court Imposes Temporary Sales Ban on Dr Reddy's Generic Heartburn Drug
Dr Reddy's Laboratories Ltd, India's second largest drug maker by sales, said on Tuesday it had been temporarily barred by a US court from selling its generic form of blockbuster heartburn drug Nexium in the United States.
-
AstraZeneca, Dr Reddy's Ink Diabetes Drug Distribution Pact
AstraZeneca Pharma India and Dr Reddy's Laboratories on Friday entered into a distribution agreement for two drugs - Riax and Riax-M - used for treatment of diabetes in India.
-
Dr Reddy's to Buy Select Brands From UCB for $128 Million
The deal will help Dr Reddy's strengthen its presence in dermatology, pediatrics and respiratory products, the company said in a statement to the Bombay Stock Exchange.
